A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
M.D. Anderson Cancer Center
West German Study Group
University of Eastern Finland
Institut du Cancer de Montpellier - Val d'Aurelle
AstraZeneca
Università Vita-Salute San Raffaele
Yale University
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio
Assistance Publique - Hôpitaux de Paris
AVEO Pharmaceuticals, Inc.
Institute of Hematology & Blood Diseases Hospital, China
Lisata Therapeutics, Inc.
Sun Yat-sen University
Engeneic Pty Limited
AtlasMedx, Incorporated
University of California, San Francisco
Stanford University
Stanford University
Pfizer
Institut Bergonié
University of Illinois at Chicago
Centre hospitalier de l'Université de Montréal (CHUM)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
University of California, San Diego
AC Camargo Cancer Center
Brown University
M.D. Anderson Cancer Center
University of Pennsylvania
Weill Medical College of Cornell University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kyorin University
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
University of California, San Francisco
Northwestern University
Fudan University
Mansoura University
Shanghai Zhongshan Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Shanghai Zhongshan Hospital
Peking University People's Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Technical University of Munich
Celgene
Mansoura University
AstraZeneca
University of Maryland, Baltimore
Assistance Publique - Hôpitaux de Paris
Centre Leon Berard